BioStem Issued Series A and B Stock Purchase Warrants
BioStem Technologies issued five-year Series A and twenty-four-month Series B warrants to purchase Common Stock. This filing details the warrant terms and exercise options for investors.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
START FREE — 10,000 calls/day, no key needed